Mechanism and function of DNA replication-independent DNA-protein crosslink repair via the SUMO-RNF4 pathway.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
15 09 2021
Historique:
revised: 03 07 2021
received: 29 11 2020
accepted: 12 07 2021
pubmed: 5 8 2021
medline: 15 12 2021
entrez: 4 8 2021
Statut: ppublish

Résumé

DNA-protein crosslinks (DPCs) obstruct essential DNA transactions, posing a serious threat to genome stability and functionality. DPCs are proteolytically processed in a ubiquitin- and DNA replication-dependent manner by SPRTN and the proteasome but can also be resolved via targeted SUMOylation. However, the mechanistic basis of SUMO-mediated DPC resolution and its interplay with replication-coupled DPC repair remain unclear. Here, we show that the SUMO-targeted ubiquitin ligase RNF4 defines a major pathway for ubiquitylation and proteasomal clearance of SUMOylated DPCs in the absence of DNA replication. Importantly, SUMO modifications of DPCs neither stimulate nor inhibit their rapid DNA replication-coupled proteolysis. Instead, DPC SUMOylation provides a critical salvage mechanism to remove DPCs formed after DNA replication, as DPCs on duplex DNA do not activate interphase DNA damage checkpoints. Consequently, in the absence of the SUMO-RNF4 pathway cells are able to enter mitosis with a high load of unresolved DPCs, leading to defective chromosome segregation and cell death. Collectively, these findings provide mechanistic insights into SUMO-driven pathways underlying replication-independent DPC resolution and highlight their critical importance in maintaining chromosome stability and cellular fitness.

Identifiants

pubmed: 34346517
doi: 10.15252/embj.2020107413
pmc: PMC8441304
doi:

Substances chimiques

Nuclear Proteins 0
RNF4 protein, human 0
Small Ubiquitin-Related Modifier Proteins 0
Transcription Factors 0
Ubiquitin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e107413

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C434/A21747
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 217196/Z/19/Z
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Published under the terms of the CC BY 4.0 license.

Références

PLoS One. 2013 Aug 06;8(8):e71960
pubmed: 23936535
Mol Cell. 2019 Feb 7;73(3):574-588.e7
pubmed: 30595436
Mol Cell. 2016 Nov 17;64(4):704-719
pubmed: 27871366
Science. 2017 Sep 29;357(6358):1412-1416
pubmed: 28912134
Dev Cell. 2020 Jan 6;52(1):53-68.e6
pubmed: 31839538
Nat Protoc. 2006;1(5):2305-14
pubmed: 17406472
Genetics. 2017 Aug;206(4):1807-1821
pubmed: 28550017
Sci Transl Med. 2016 Oct 26;8(362):362ps17
pubmed: 27797957
Mol Cell Biol. 2005 Aug;25(16):7021-32
pubmed: 16055714
EMBO J. 2021 Jan 15;40(2):e105513
pubmed: 33197065
Mol Cell. 2020 Sep 3;79(5):824-835.e5
pubmed: 32649882
Science. 2015 May 1;348(6234):1253671
pubmed: 25931565
Nature. 2009 Dec 17;462(7275):935-9
pubmed: 20016603
Mol Cell. 2015 Jan 8;57(1):150-64
pubmed: 25557546
Free Radic Biol Med. 2013 Mar;56:89-101
pubmed: 23195683
Mol Cell. 2020 Oct 1;80(1):102-113.e6
pubmed: 32853547
DNA Repair (Amst). 2013 Sep;12(9):761-73
pubmed: 23871147
Curr Biol. 2004 Apr 6;14(7):611-7
pubmed: 15062103
J Cell Sci. 1993 Nov;106 ( Pt 3):983-94
pubmed: 8308077
J Biol Chem. 2017 Jun 16;292(24):10230-10238
pubmed: 28455449
FASEB J. 2009 Nov;23(11):3978-89
pubmed: 19622798
Nat Struct Mol Biol. 2011 Aug 21;18(9):1052-9
pubmed: 21857666
Genes Dev. 2012 Feb 15;26(4):350-5
pubmed: 22345516
Nat Chem Biol. 2017 Nov;13(11):1164-1171
pubmed: 28892090
J Biol Chem. 2000 Aug 25;275(34):26066-73
pubmed: 10862613
PLoS Genet. 2011 Mar;7(3):e1001320
pubmed: 21408210
Science. 2020 Apr 3;368(6486):
pubmed: 32241924
EMBO J. 2005 Jun 15;24(12):2172-82
pubmed: 15933717
Cell Rep. 2019 Mar 19;26(12):3336-3346.e4
pubmed: 30893605
Cell. 2019 Jan 10;176(1-2):167-181.e21
pubmed: 30595447
Methods Mol Biol. 2011;761:151-61
pubmed: 21755447
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Dev Cell. 2020 Jan 6;52(1):38-52.e10
pubmed: 31839537
Mol Cell. 2021 Feb 4;81(3):442-458.e9
pubmed: 33321094
Sci Rep. 2016 May 17;6:26178
pubmed: 27185577
Cell. 2014 Jul 17;158(2):327-338
pubmed: 24998930
EMBO J. 2009 Nov 18;28(22):3534-48
pubmed: 19779455
Oncogene. 2014 Feb 13;33(7):921-7
pubmed: 23396363
EMBO J. 2012 Jun 29;31(13):3008-19
pubmed: 22635276
Mol Cell. 2017 Jun 1;66(5):581-596.e6
pubmed: 28552615
Cell. 2014 Oct 9;159(2):346-57
pubmed: 25303529
Nat Genet. 2014 Nov;46(11):1239-44
pubmed: 25261934
Genes Dev. 2012 Jun 1;26(11):1179-95
pubmed: 22661229
Mol Cell. 2016 Nov 17;64(4):688-703
pubmed: 27871365
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
J Biol Chem. 2002 Jan 25;277(4):2958-64
pubmed: 11709553
EMBO J. 2019 Apr 15;38(8):
pubmed: 30914427
Nat Commun. 2020 Mar 12;11(1):1318
pubmed: 32165630
Elife. 2016 Oct 08;5:
pubmed: 27718356
Cold Spring Harb Protoc. 2019 Mar 1;2019(3):
pubmed: 29769389
Cell Syst. 2019 Feb 27;8(2):163-167.e2
pubmed: 30797774
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Methods Mol Biol. 2009;521:229-52
pubmed: 19563110
Mutat Res. 2011 Jun 3;711(1-2):113-22
pubmed: 21185846
DNA Repair (Amst). 2020 Oct;94:102924
pubmed: 32683310
Mol Cell. 2020 Mar 5;77(5):1066-1079.e9
pubmed: 31902667
Genetics. 2016 Dec;204(4):1433-1445
pubmed: 27770033
Nature. 2016 Oct 19;538(7625):336-343
pubmed: 27762356
J Biol Chem. 2010 May 7;285(19):14415-23
pubmed: 20228053
Nat Cell Biol. 2008 May;10(5):538-46
pubmed: 18408734
Acc Chem Res. 2015 Jun 16;48(6):1631-44
pubmed: 26032357
J Cell Biol. 2012 Apr 16;197(2):189-99
pubmed: 22492721
Nucleic Acids Res. 2015 Jun 23;43(11):5465-75
pubmed: 25948581
Sci Adv. 2020 Nov 13;6(46):
pubmed: 33188014
J Biol Chem. 2020 Jun 19;295(25):8350-8362
pubmed: 32350109

Auteurs

Julio C Y Liu (JCY)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Ulrike Kühbacher (U)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Nicolai B Larsen (NB)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Nikoline Borgermann (N)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Dimitriya H Garvanska (DH)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Ivo A Hendriks (IA)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Leena Ackermann (L)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Peter Haahr (P)

Netherlands Cancer Institute, Amsterdam, The Netherlands.

Irene Gallina (I)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Claire Guérillon (C)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Emma Branigan (E)

Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.

Ronald T Hay (RT)

Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.

Yoshiaki Azuma (Y)

Department of Molecular Biosciences, University of Kansas, Lawrence, KS, USA.

Michael Lund Nielsen (ML)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Julien P Duxin (JP)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Niels Mailand (N)

Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH